{
    "pmid": "41386993",
    "title": "Anatomic versus reverse total shoulder replacement for patients with osteoarthritis and intact rotator cuff: the RAPSODI-UK randomised controlled trial protocol.",
    "abstract": "Shoulder osteoarthritis most commonly affects older adults, causing pain, reduced function and quality of life. Total shoulder replacements (TSRs) are indicated once other non-surgical options no longer provide adequate pain relief. Two main types of TSRs are widely used: anatomic TSR (aTSR) and reverse TSR (rTSR). It is not clear whether one TSR type provides better short- or long-term outcomes for patients, and which, if either, is more cost-effective for the National Health Service (NHS). RAPSODI-UK is a multi-centre, pragmatic, two-parallel arm, superiority randomised controlled trial comparing the clinical- and cost-effectiveness of aTSR versus rTSR for adults aged 60+ withâ€‰a primary diagnosis of osteoarthritis, an intact rotator cuff and bone stock suitable for TSR. Participants in both arms of the trial will receive usual post-operative rehabilitation. We aim to recruit 430 participants from approximately 28 NHS sites across the UK. The primary outcome is the Shoulder Pain and Disability Index (SPADI) at 2 years post-randomisation. Outcomes will be collected at 3, 6, 12, 18 and 24 months after randomisation. Secondary outcomes include the pain and function subscales of the SPADI, the Oxford Shoulder Score, health-related quality of life (EQ-5D-5L), complications, range of movement and strength, revisions and mortality. The between-group difference in the primary outcome will be derived from a constrained longitudinal data analysis model. We will also undertake a full health economic evaluation and conduct qualitative interviews to explore perceptions of acceptability of the two types of TSR and experiences of recovery with a sample of participants. Ethics committee approval for this trial was obtained (London - Queen Square Research Ethics Committee, Rec Reference 22/LO/0617) on 4 October 2022. The results of the main trial will be submitted for publication in a peer-reviewed journal and using other professional and media outlets. ISRCTN12216466.",
    "disease": "osteoarthritis",
    "clean_text": "anatomic versus reverse total shoulder replacement for patients with osteoarthritis and intact rotator cuff the rapsodi uk randomised controlled trial protocol shoulder osteoarthritis most commonly affects older adults causing pain reduced function and quality of life total shoulder replacements tsrs are indicated once other non surgical options no longer provide adequate pain relief two main types of tsrs are widely used anatomic tsr atsr and reverse tsr rtsr it is not clear whether one tsr type provides better short or long term outcomes for patients and which if either is more cost effective for the national health service nhs rapsodi uk is a multi centre pragmatic two parallel arm superiority randomised controlled trial comparing the clinical and cost effectiveness of atsr versus rtsr for adults aged with a primary diagnosis of osteoarthritis an intact rotator cuff and bone stock suitable for tsr participants in both arms of the trial will receive usual post operative rehabilitation we aim to recruit participants from approximately nhs sites across the uk the primary outcome is the shoulder pain and disability index spadi at years post randomisation outcomes will be collected at and months after randomisation secondary outcomes include the pain and function subscales of the spadi the oxford shoulder score health related quality of life eq d l complications range of movement and strength revisions and mortality the between group difference in the primary outcome will be derived from a constrained longitudinal data analysis model we will also undertake a full health economic evaluation and conduct qualitative interviews to explore perceptions of acceptability of the two types of tsr and experiences of recovery with a sample of participants ethics committee approval for this trial was obtained london queen square research ethics committee rec reference lo on october the results of the main trial will be submitted for publication in a peer reviewed journal and using other professional and media outlets isrctn"
}